GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
₹2,740.00
arrow_upward
+0.98%(+26.60) 1D
Nov 20, 3:30:03 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
₹2,701.00
High
₹2,748.00
Low
₹2,680.00
Mkt. cap
464.17B
Avg. vol.
94.32K
Volume
84.48K
Dividend
2.08%
Quarterly dividend
₹14.25
Ex-dividend date
May 29, 2026
P/E ratio
40.48
52-wk high
₹3,120.70
52-wk low
₹2,088.10
EPS
₹67.68
Shares outstanding
169.41M
No. of employees
3K
Open
₹2,701.00
High
₹2,748.00
Low
₹2,680.00
Mkt. cap
464.17B
Avg. vol.
94.32K
Volume
84.48K
Dividend
2.08%
Quarterly dividend
₹14.25
Ex-dividend date
May 29, 2026
P/E ratio
40.48
52-wk high
₹3,120.70
52-wk low
₹2,088.10
EPS
₹67.68
Shares outstanding
169.41M
No. of employees
3K
News stories
From web sources and news partners
Traders Union
·
5 hours ago
VIX fear index hits highest level since April 2025 as S&P 500 plunges
The Loadstar
·
2 hours ago
CNBC: S&P 500 and Dow close in correction; Nasdaq erases 2026 gain as AI rout picks up steam
Trefis
·
3 hours ago
25 S&P 500 Stocks Just Made New 52-Week Lows
JournalArta
·
31 minutes ago
S&P 500 Falls Into Correction as AI Worries Deepen
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees3.1K
FoundedNov 13, 1924
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteindia-pharma.gsk.com